Search research articles
Contact Us
Filters
Showing results (41-50 of 429) with videos related to
Page
of 43
Sort By:
The Journal of Infectious Diseases
|
November 19, 2011
Management of chronic hepatitis B e antigen-negative disease: another step forward
George K K Lau, Fu-Sheng Wang
Cellular & Molecular Immunology
|
October 11, 2011
The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC)
Lifeng Wang, Zheng Zhang, Fu-Sheng Wang
Military Medical Research
|
June 13, 2022
Monkeypox outbreak: A novel threat after COVID-19?
Yang Zhang, Ji-Yuan Zhang, Fu-Sheng Wang
Journal of Internal Medicine
|
July 28, 2015
Human autoimmune diseases: a comprehensive update
Lifeng Wang, Fu-Sheng Wang, M Eric Gershwin
Infectious Diseases & Immunity
|
June 22, 2026
New hope for cure of HIV-infected patients
Yan-Mei Jiao, Chao Zhang, Fu-Sheng Wang
World Journal of Gastroenterology
|
January 1, 2003
Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro
Ming Shi, Fu-Sheng Wang, Zu-Ze Wu
Cell Communication & Adhesion
|
May 15, 2003
Src-/- fibroblasts are defective in their ability to disassemble focal adhesions in response to phorbol ester/hyaluronan treatment
Christine L Hall, Fu-Sheng Wang, Eva Turley
HIV Medicine
|
March 16, 2022
Snapshot of clinical problems among people living with HIV in China
Yan-Mei Jiao, Zhe Xu, Fu-Sheng Wang
Current Opinion in Gastroenterology
|
February 18, 2016
Primary biliary cholangitis in China
Lifeng Wang, M Eric Gershwin, Fu-Sheng Wang
Cellular & Molecular Immunology
|
November 16, 2021
Boosting viral-specific immunotherapy for chronic hepatitis B treatment
Jin Fan, Jun-Liang Fu, Fu-Sheng Wang
Page
of 43
Search research articles
Search
Showing results (41-50 of 429) with videos related to
Sort By:
Page
of 43
The Journal of Infectious Diseases
|
November 19, 2011
Management of chronic hepatitis B e antigen-negative disease: another step forward
George K K Lau, Fu-Sheng Wang
Cellular & Molecular Immunology
|
October 11, 2011
The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC)
Lifeng Wang, Zheng Zhang, Fu-Sheng Wang
Military Medical Research
|
June 13, 2022
Monkeypox outbreak: A novel threat after COVID-19?
Yang Zhang, Ji-Yuan Zhang, Fu-Sheng Wang
Journal of Internal Medicine
|
July 28, 2015
Human autoimmune diseases: a comprehensive update
Lifeng Wang, Fu-Sheng Wang, M Eric Gershwin
Infectious Diseases & Immunity
|
June 22, 2026
New hope for cure of HIV-infected patients
Yan-Mei Jiao, Chao Zhang, Fu-Sheng Wang
World Journal of Gastroenterology
|
January 1, 2003
Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro
Ming Shi, Fu-Sheng Wang, Zu-Ze Wu
Cell Communication & Adhesion
|
May 15, 2003
Src-/- fibroblasts are defective in their ability to disassemble focal adhesions in response to phorbol ester/hyaluronan treatment
Christine L Hall, Fu-Sheng Wang, Eva Turley
HIV Medicine
|
March 16, 2022
Snapshot of clinical problems among people living with HIV in China
Yan-Mei Jiao, Zhe Xu, Fu-Sheng Wang
Current Opinion in Gastroenterology
|
February 18, 2016
Primary biliary cholangitis in China
Lifeng Wang, M Eric Gershwin, Fu-Sheng Wang
Cellular & Molecular Immunology
|
November 16, 2021
Boosting viral-specific immunotherapy for chronic hepatitis B treatment
Jin Fan, Jun-Liang Fu, Fu-Sheng Wang
Page
of 43